{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:42Z","timestamp":1787169882300,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Glaucoma is the leading cause of global irreversible blindness. The goal of management in glaucoma lies in its early detection and treatment to prevent further optic neuropathy. Available equipment for early glaucoma detection is not cost-effective or readily available in resource-scarce settings such as Nigeria. Thus, there is a need for a simple cost-effective tool to detect glaucomatous central visual field (CVF) defects in all the stages of glaucoma within the community in resource scarce-settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>The aim of this article is to determine the validity of the Amsler grid in detecting central glaucomatous visual field defects in primary open angle glaucoma (POAG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a cross-sectional study of follow-up glaucoma patients at a secondary eye care hospital in Nigeria. All patients had detailed ophthalmic examination in addition to 24-2 and 10-2 CVF tests and Amsler grid test. POAG was classified using the Hodapp\u2013Parrish\u2013Anderson criteria into mild, moderate, and severe on 24-2 CVF. The diagnostic validity of the Amsler grid was calculated using the 10-2 CVF as a reference standard. Regression analyses were performed between the Amsler grid scotoma area and 10-2 CVF parameters [mean deviation (MD), scotoma extent (SE), and scotoma mean depth (SMD)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 150 eyes of 150 patients were enrolled. The sensitivity, specificity, and positive predictive value and negative predictive value of the Amsler grid compared with the 10-2 CVF was 49.5%, 95.9%, 96.2%, and 47.9%, respectively, with an area under curve of 0.7. Sensitivity increased with increasing severity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) from 20.0%, 31.0%, and 76.6% in mild, moderate, and severe POAG, respectively. The Amsler grid scotoma area had the strongest relationship with the 10-2 MD, followed by 10-2 SE and 10-2 SMD with a quadratic\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      of 0.579, 0.370, and 0.307, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The Amsler grid has a low sensitivity in mild-to-moderate POAG. However, it may serve as an adjunctive tool in resource-scarce settings for detection of severe POAG in the community by primary eye care providers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jwas.jwas_275_22","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:40:14Z","timestamp":1694760014000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Amsler Grid Versus 10-2 Test in Primary Open Angle Glaucoma"],"prefix":"10.4103","volume":"13","author":[{"given":"Temitope Mariam","family":"Gbadegesin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusola","family":"Olawoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarela Frederick","family":"Sarimiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatobi Olalekan","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedictus G.K.","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20240907","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R2-14-20240907","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"R3-14-20240907","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R4-14-20240907","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ajo.2004.04.054","article-title":"Risk assessment in the management of patients with ocular hypertension","volume":"138","author":"Weinreb","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R5-14-20240907","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10792-014-9903-2","article-title":"Glaucoma in southwest Nigeria: Clinical presentation, family history and perceptions","volume":"34","author":"Adekoya","year":"2014","journal-title":"Int Ophthalmol"},{"key":"R6-14-20240907","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1258\/004947506776593323","article-title":"Pattern of presentation of primary open-angle glaucoma in Benin city, Nigeria","volume":"36","author":"Omoti","year":"2006","journal-title":"Trop Doct"},{"key":"R7-14-20240907","doi-asserted-by":"crossref","first-page":"OCT80","DOI":"10.1167\/iovs.15-18931","article-title":"Technology and the glaucoma suspect","volume":"57","author":"Blumberg","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-14-20240907","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0161-6420(03)00541-4","article-title":"Evaluating several sources of variability for standard and swap visual fields in glaucoma patients, suspects, and normals","volume":"110","author":"Blumenthal","year":"2003","journal-title":"Ophthalmology"},{"key":"R9-14-20240907","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/1117-1936.165474","article-title":"Managing glaucoma in Lagos State, Nigeria\u2014Availability of human resources and equipment","volume":"20","author":"Adekoya","year":"2013","journal-title":"Niger Postgrad Med J"},{"key":"R10-14-20240907","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ophtha.2011.03.019","article-title":"Assessment of visual function in glaucoma: A report by the American Academy of Ophthalmology","volume":"118","author":"Jampel","year":"2011","journal-title":"Ophthalmology"},{"key":"R11-14-20240907","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2017.09.020","article-title":"Comparison of glaucoma progression detection by optical coherence tomography and visual field","volume":"184","author":"Zhang","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R12-14-20240907","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamaophthalmol.2013.7656","article-title":"Prevalence and nature of early glaucomatous defects in the central 10\u00b0 of the visual field","volume":"132","author":"Traynis","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R13-14-20240907","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.5.2.15","article-title":"The 24-2 visual field test misses central macular damage confirmed by the 10-2 visual field test and optical coherence tomography","volume":"5","author":"Grillo","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"R14-14-20240907","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2017.04.021","article-title":"24-2 visual fields miss central defects shown on 10-2 tests in glaucoma suspects, ocular hypertensives, and early glaucoma","volume":"124","author":"De Moraes","year":"2017","journal-title":"Ophthalmology"},{"key":"R15-14-20240907","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/IJG.0000000000001010","article-title":"Four questions for every clinician diagnosing and monitoring glaucoma","volume":"27","author":"Hood","year":"2018","journal-title":"J Glaucoma"},{"key":"R16-14-20240907","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/112067210901900515","article-title":"Novel 3D computer-automated threshold Amsler grid visual field testing of scotomas in patients with glaucoma","volume":"19","author":"Nguyen","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R17-14-20240907","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ophtha.2012.11.043","article-title":"How does glaucoma look?: Patient perception of visual field loss","volume":"120","author":"Crabb","year":"2013","journal-title":"Ophthalmology"},{"key":"R18-14-20240907","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0161-6420(96)30431-4","article-title":"Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population","volume":"103","author":"Ariyasu","year":"1996","journal-title":"Ophthalmology"},{"key":"R19-14-20240907","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archopht.1993.01090060064024","article-title":"Validity and interpretation of Amsler grid reports","volume":"111","author":"Schuchard","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R20-14-20240907","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/ICU.0b013e32835fd7dd","article-title":"Detection of new-onset choroidal neovascularization","volume":"24","author":"Do","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"R21-14-20240907","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00006982-200506000-00008","article-title":"Comparison of the original Amsler grid with the modified Amsler grid: Result for patients with age-related macular degeneration","volume":"25","author":"Augustin","year":"2005","journal-title":"Retina"},{"key":"R22-14-20240907","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bjo.37.9.521","article-title":"Earliest symptoms of diseases of the macula","volume":"37","author":"Amsler","year":"1953","journal-title":"Br J Ophthalmol"},{"key":"R23-14-20240907","doi-asserted-by":"crossref","first-page":"e0184230","DOI":"10.1371\/journal.pone.0184230","article-title":"Assessment of patient perception of glaucomatous visual field loss and its association with disease severity using Amsler grid","volume":"12","author":"Fujitani","year":"2017","journal-title":"PLoS ONE"},{"key":"R24-14-20240907","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ophtha.2015.12.003","article-title":"Efficacy of the Amsler grid test in evaluating glaucomatous central visual field defects","volume":"123","author":"Su","year":"2016","journal-title":"Ophthalmology"},{"key":"R25-14-20240907","doi-asserted-by":"crossref","first-page":"e0230017","DOI":"10.1371\/journal.pone.0230017","article-title":"Amsler grid test for detection of advanced glaucoma in Ethiopia","volume":"15","author":"Gessesse","year":"2020","journal-title":"PLoS ONE"},{"key":"R26-14-20240907","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajo.2016.05.003","article-title":"Prevalence, features, and severity of glaucomatous visual field loss measured with the 10-2 achromatic threshold visual field test","volume":"168","author":"Sullivan-Mee","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R27-14-20240907","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.survophthal.2006.12.008","article-title":"Staging functional damage in glaucoma: Review of different classification methods","volume":"52","author":"Brusini","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"R28-14-20240907","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/bjo.2006.095315","article-title":"The Amsler chart: Absence of evidence is not evidence of absence","volume":"91","author":"Crossland","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R29-14-20240907","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/350699a0","article-title":"Perceptual filling in of artificially induced scotomas in human vision","volume":"350","author":"Ramachandran","year":"1991","journal-title":"Nature"},{"key":"R30-14-20240907","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archopht.1969.00990010194009","article-title":"The size and location of the normal blind spot","volume":"81","author":"Armaly","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"R31-14-20240907","first-page":"520","article-title":"Threshold Amsler grid testing","volume":"104","author":"Wall","year":"1986","journal-title":"Cross-polarizing lenses enhance yield. Arch Ophthalmol"},{"key":"R32-14-20240907","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00006982-200506000-00009","article-title":"Scotomas of age-related macular degeneration detected and characterized by means of a novel three-dimensional computer-automated visual field test","volume":"25","author":"Nazemi","year":"2005","journal-title":"Retina"},{"key":"R33-14-20240907","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjo.2007.116103","article-title":"Early detection of glaucoma by means of a novel 3d computer-automated visual field test","volume":"91","author":"Nazemi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R34-14-20240907","first-page":"375","article-title":"The current status of glaucoma and glaucoma care in Sub-Saharan Africa","volume":"7","author":"Kyari","year":"2018","journal-title":"Asia-Pacific J Ophthalmol"},{"key":"R36-14-20240907","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.optm.2007.09.017","article-title":"Macular function surveillance revisited","volume":"79","author":"Trevino","year":"2008","journal-title":"Optometry"},{"key":"R37-14-20240907","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00055735-199404000-00011","article-title":"The value of different screening techniques for glaucoma","volume":"5","author":"Wilson","year":"1994","journal-title":"Curr Opin Ophthalmol"},{"key":"R38-14-20240907","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.survophthal.2008.08.003","article-title":"Diagnostic tools for glaucoma detection and management","volume":"53","author":"Sharma","year":"2008","journal-title":"Surv Ophthalmol"}],"container-title":["Journal of West African College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jwas.jwas_275_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:28Z","timestamp":1787166868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jwas.jwas_275_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jwas.jwas_275_22","relation":{},"ISSN":["2276-6944"],"issn-type":[{"value":"2276-6944","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}